All News #Library
Biotech
Eli to buy Boston`s Kelonia for up to $7 Billion in Cancer Push
21 Apr 2026 //
BIOSPACE
Kelonia Therapeutics Clears FDA (IND) For KLN-1010, CAR-T Therapy
07 Jan 2026 //
PHARMIWEB
Kelonia Therapeutics Unveils Phase 1 Data On KLN-1010 BCMA CAR-T
09 Dec 2025 //
PHARMIWEB
Kelonia Therapeutics Presents First-In-Human BCMA CAR-T Data
24 Nov 2025 //
BUSINESSWIRE
Kelonia Doses First Patient In Ph 1 inMMyCAR For Multiple Myeloma
19 Aug 2025 //
BUSINESSWIRE
Kelonia Therapeutics to Present iGPS® Data at ASGCT 2025 Meeting
09 May 2025 //
BUSINESSWIRE
Astellas pursues ‘convertible’ in vivo CAR-T cell therapies with Kelonia
16 Feb 2024 //
ENDPTS

Market Place
Sourcing Support